sr 48692 has been researched along with atropine in 3 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 26,711 | 1,259 | 1,697 |
| Protein | Taxonomy | sr 48692 (IC50) | atropine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mulè, F; Serio, R | 1 |
| Becker, H; Horstmann, O; Nustede, R; Schemminger, R; Schmidt, WE; Sikovec, N | 1 |
| Fujita, A; Hata, F; Ohta, M; Okishio, Y; Takeuchi, T; Takewaki, T; Waseda, K | 1 |
3 other study(ies) available for sr 48692 and atropine
| Article | Year |
|---|---|
Mode and mechanism of neurotensin action in rat proximal colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Apamin; Atropine; Bethanechol; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cholinergic Agonists; Cholinergic Antagonists; Colon; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Neurotensin; Nifedipine; Pyrazoles; Quinolines; Rats; Rats, Wistar; Receptors, Neurotensin | 1997 |
On the effect of xenin and xenin fragments on exocrine pancreas secretion in vivo.
Topics: Adjuvants, Anesthesia; Animals; Atropine; Dogs; Dose-Response Relationship, Drug; Fistula; Gastrointestinal Hormones; Injections, Intravenous; Neurotensin; Pancreas; Peptide Fragments; Peptides; Pyrazoles; Quinolines; Receptors, Neurotensin | 1999 |
Participation of ATP in nonadrenergic, noncholinergic relaxation of longitudinal muscle of wistar rat jejunum.
Topics: Adenosine Phosphosulfate; Adenosine Triphosphate; Animals; Apamin; Atropine; Drug Administration Schedule; Electric Stimulation; Guanethidine; Ileum; Jejunum; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Neurotensin; Papaverine; Purinergic Antagonists; Purinergic P2 Receptor Antagonists; Pyrazoles; Quinolines; Rats; Rats, Wistar; Receptors, Purinergic; Receptors, Purinergic P2; Thapsigargin | 2005 |